APA (7th ed.) Citation

F, L., ME, M., D, B., S, S., KC, L., C, K., . . . T, K. (2025). Preclinical Evaluation of [212Pb]Pb-ADVC001: A Prostate-Specific Membrane Antigen-Targeted α-Therapy for Prostate Cancer. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 66(11), 1703. https://doi.org/10.2967/jnumed.125.269707

Chicago Style (17th ed.) Citation

F, Liu, et al. "Preclinical Evaluation of [212Pb]Pb-ADVC001: A Prostate-Specific Membrane Antigen-Targeted α-Therapy for Prostate Cancer." Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine 66, no. 11 (2025): 1703. https://doi.org/10.2967/jnumed.125.269707.

MLA (9th ed.) Citation

F, Liu, et al. "Preclinical Evaluation of [212Pb]Pb-ADVC001: A Prostate-Specific Membrane Antigen-Targeted α-Therapy for Prostate Cancer." Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine, vol. 66, no. 11, 2025, p. 1703, https://doi.org/10.2967/jnumed.125.269707.

Warning: These citations may not always be 100% accurate.